BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE

BIOMARKER IDENTIFICATION IN BREAST CANCER: BETA-ADRENERGIC RECEPTOR SIGNALING AND PATHWAYS TO THERAPEUTIC RESPONSE

Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasi...

Full description

Bibliographic Details
Main Authors: Liana E. Kafetzopoulou, David J. Boocock, Gopal Krishna R. Dhondalay, Desmond G. Powe, Graham R. Ball
Format: Article
Language:English
Published: Elsevier 2013-03-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Artificial Neural Networks
Microarray Data
Beta-2-Adrenergic Receptor
beta-blockers
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037014601124

Internet

http://www.sciencedirect.com/science/article/pii/S2001037014601124

Similar Items